Results of the treatment of chronic hepatitis C genotype 4: A comparative analysis with genotype 1;Resultados del tratamiento de la hepatitis crónica por VHC genotipo 4. Un análisis comparativo con el genotipo 1

Revista Espanola de Enfermedades Digestivas

Volumn 100, Issue 4, 2008, Pages 208-211

  Lopez Alonso G ^a   Agreda M ^a   Devesa, M J ^a   Cuenca, F ^a   Suarez A ^a   Ortega, L ^a   Diaz Rubio M ^a   Ladero, José María ^a,b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Chronic hepatitis C; Hepatitis C virus genotype 4; Pegylated interferon; Ribavirin

Indexed keywords

PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC ANALYSIS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; NONHUMAN; SPAIN; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; RIBAVIRIN; SPAIN; TREATMENT OUTCOME;

EID: 47049117387     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Simmonds P, Bukh J, Combet C, Deléage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatol 2005; 42: 962-73.
2. Strader DB, Wright T, Thomas DL, Seeff LB. AASLD practice guideline. Diagnosis, management, and treatment of hepatitis C. Hepatol 2004; 39: 1147-71 (Erratum in Hepatology 2004; 40: 269).
3. Dienstag JL, McHutchinson JG. AGA technical review on the management of hepatitis C. Gastroenterology 2006; 130: 231-64.
4. Bruguera M, Bañares R, Córdoba J, Jardí R, González-Lahoz J, Ladero JM, et al. Documento de consenso de la AEEH sobre el tratamiento de las infecciones por los virus de las hepatitis B y C. Gastroenterol Hepatol 2006; 29 (Supl. 2): 216-30.
5. Trapero-Marugán M, Moreno-Monteagudo JA, García-Buey L, Borque J, Medina J, García-Sánchez A, et al. Clinical and pathological characteristics and response to combination therapy of genotype 4 chronic hepatitis C patients: Experience from an Spanish center. J Chemother 2007; 19: 423-7.
6. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Research 1996; 6: 989-94.
7. Knodell RG, Isaac KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
8. Khuroo MS, Khuroo MS, Dahab ST. Meta-analysis: A randomized trial of peginterferon plus ribavirin for the initial treatment of chronic hepatitis C genotype 4. Aliment Pharmacol Ther 2004; 20: 931-8.
9. Kamal SM, El Tawil AA, Nakano T, He Q, Rasenack J, Hasan SA, et al. Peginterferon (alpha)-2b and ribavirin therapy in chronic hepatitis C genotype 4: Impact of treatment duration and viral kinetics on sustained virological response. Gut 2005; 54: 858-66.
10. Hasan F, Asker H, Al-Khaldi J, Siddique I, Al-Ajmi M, Owaid S, et al. Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4. Am J Gastroenterol 2004; 99: 1733-7.
11. Alfaleh FZ, Hadad Q, Khuroo MS, Aljumah A, Algamedi A, Alashgar H, et al. Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4. Liver Int 2004; 24: 568-74.
12. Derbala M, Amer A, Bener A, López AC, Omar M, El Ghannam M. Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis. J Viral Hepat 2005; 12: 380-5.
13. Legrand-Abravanel F, Nicot F, Boulestin A, Sandres-Sauné K, Vinel JP, Alric L, et al. Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection. J Med Virol 2005; 77: 66-9.
14. Roulot D, Bourcier V, Grando V, Deny P, Baazia Y, Fontaine H, et al. Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection. J Viral Hepatol 2007; 14: 460-7.